Activity of ZD1839 (gefitinib, Iressa™) in previously treated patients with recurrent and advanced non-small-cell lung cancer

Angelia D. Gibson, Mark Socinski, Chandra P. Belani, Vinay K. Jain

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of ZD1839 (gefitinib, Iressa™) in previously treated patients with recurrent and advanced non-small-cell lung cancer'. Together they form a unique fingerprint.